GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

The company had a market cap of $2.7 billion, as of July 18, 2024. Hosni was previously the regional president for Africa and the Middle East at Pfizer, and commercial director for Egypt and Sudan at ...